Literature DB >> 22067086

Management of patients with transient ischemic attack is safe in an outpatient clinic based on rapid diagnosis and risk stratification.

Sabine Hörer1, Gernot Schulte-Altedorneburg, Roman L Haberl.   

Abstract

BACKGROUND: Transient ischemic attack (TIA) patients are at high risk of short-term stroke, myocardial infarction and vascular death. Stroke risk is reduced by immediate treatment initialization. Stroke unit treatment is recommended for TIA patients. We established an outpatient TIA clinic to address the question whether outpatient evaluation of suspected TIA is safe.
METHODS: TIA workup included cerebral imaging, duplex sonography, transcranial Doppler screening for patent foramen ovale, electrocardiography, blood tests, ABCD(2) score and ankle-brachial index within one day. TIA patients received secondary prophylaxis immediately. TIA patients fulfilling predefined criteria for high early stroke risk (ABCD(2) score ≥4 points and TIA within 72 h, symptomatic stenosis, newly detected atrial fibrillation, recurrent TIA) were referred to the stroke unit. The remaining patients were discharged home. 90-day telephone follow-up was obtained.
RESULTS: 123 consecutive patients with suspected TIA (53 male, age 59 ± 17.2 years) were prospectively evaluated. TIA or minor stroke was diagnosed in 69 (56%), and TIA mimics in 54 (44%) patients. Median time from symptom onset to presentation was 48 h (1 h to 3 months). Patients with TIA/minor stroke presented significantly more frequently with ABCD(2) score ≥4 points (p = 0.021). Twelve patients (9.8%) were admitted to the stroke unit. There were 2 strokes during follow-up. The stroke rate was 1.6% within all patients, and 2.9% within the subgroup of patients with TIA/minor stroke, compared to 5.7% predicted by the ABCD(2) score. Other vascular end points were not found.
CONCLUSION: Based on risk stratification, outpatient evaluation of TIA is safe. TIA mimics are frequent.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22067086     DOI: 10.1159/000331919

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  6 in total

Review 1.  Is Transient Ischemic Attack a Medical Emergency? An Evidence-Based Analysis.

Authors:  S Sehatzadeh
Journal:  Ont Health Technol Assess Ser       Date:  2015-02-01

2.  Long-Term Effect of Participation in an Early Exercise and Education Program on Clinical Outcomes and Cost Implications, in Patients with TIA and Minor, Non-Disabling Stroke.

Authors:  James Faulkner; Lee Stoner; Jeremy Lanford; Evan Jolliffe; Andrew Mitchelmore; Danielle Lambrick
Journal:  Transl Stroke Res       Date:  2016-11-14       Impact factor: 6.829

3.  Association between hospitalization and care after transient ischemic attack or minor stroke.

Authors:  Moira K Kapral; Ruth Hall; Jiming Fang; Peter C Austin; Frank L Silver; David J Gladstone; Leanne K Casaubon; Melissa Stamplecoski; Jack V Tu
Journal:  Neurology       Date:  2016-03-25       Impact factor: 9.910

4.  Implementation of a Rapid, Protocol-based TIA Management Pathway.

Authors:  Susann J Jarhult; Melissa L Howell; Isabelle Barnaure-Nachbar; Yuchiao Chang; Benjamin A White; Mary Amatangelo; David F Brown; Aneesh B Singhal; Lee H Schwamm; Scott B Silverman; Joshua N Goldstein
Journal:  West J Emerg Med       Date:  2018-02-08

5.  An International Report on the Adaptations of Rapid Transient Ischaemic Attack Pathways During the COVID-19 Pandemic.

Authors:  Andy Lim; Shaloo Singhal; Philippa Lavallee; Pierre Amarenco; Peter M Rothwell; Gregory Albers; Mukul Sharma; Robert Brown; Annemarei Ranta; Mohana Maddula; Timothy Kleinig; Jesse Dawson; Mitchell S V Elkind; Maria Guarino; Shelagh B Coutts; Benjamin Clissold; Henry Ma; Thanh Phan
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-08-18       Impact factor: 2.136

6.  Long term evolution of patients treated in a TIA unit.

Authors:  Lorena Benavente; Sergio Calleja; Davinia Larrosa; Juan Vega; Gerard Mauri; Julio Pascual; Carlos H Lahoz
Journal:  Int Arch Med       Date:  2013-05-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.